Orntoft TF - Search Results

1

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells.

Herbsleb M, Birkenkamp-Demtroder K, Thykjaer T, Wiuf C, Hein AM, Orntoft TF, Dyrskjøt L. Herbsleb M, et al. Among authors: orntoft tf. BMC Med Genomics. 2008 Jul 22;1:31. doi: 10.1186/1755-8794-1-31. BMC Med Genomics. 2008. PMID: 18647386 Free PMC article.

2

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder.

Herbsleb M, Christensen OF, Thykjaer T, Wiuf C, Borre M, Orntoft TF, Dyrskjøt L. Herbsleb M, et al. Among authors: orntoft tf. BMC Cancer. 2008 Jan 31;8:37. doi: 10.1186/1471-2407-8-37. BMC Cancer. 2008. PMID: 18237400 Free PMC article.

3

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer.

Nordentoft I, Birkenkamp-Demtroder K, Agerbæk M, Theodorescu D, Ostenfeld MS, Hartmann A, Borre M, Ørntoft TF, Dyrskjøt L. Nordentoft I, et al. Among authors: orntoft tf. BMC Med Genomics. 2012 Sep 6;5:40. doi: 10.1186/1755-8794-5-40. BMC Med Genomics. 2012. PMID: 22954303 Free PMC article.

4

SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization.

Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sørensen FB, Thykjaer T, Sauter G, Jensen KM, Dyrskjøt L, Ørntoft T. Aaboe M, et al. Cancer Res. 2006 Apr 1;66(7):3434-42. doi: 10.1158/0008-5472.CAN-05-3456. Cancer Res. 2006. PMID: 16585165 Free article.

5

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.

Zieger K, Wiuf C, Jensen KM, Ørntoft TF, Dyrskjøt L. Zieger K, et al. Among authors: orntoft tf. BMC Cancer. 2009 May 16;9:149. doi: 10.1186/1471-2407-9-149. BMC Cancer. 2009. PMID: 19445696 Free PMC article.

6

Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.

Zieger K, Dyrskjøt L, Wiuf C, Jensen JL, Andersen CL, Jensen KM, Ørntoft TF. Zieger K, et al. Among authors: orntoft tf. Clin Cancer Res. 2005 Nov 1;11(21):7709-19. doi: 10.1158/1078-0432.CCR-05-1130. Clin Cancer Res. 2005. PMID: 16278391

7

Identifying distinct classes of bladder carcinoma using microarrays.

Dyrskjøt L, Thykjaer T, Kruhøffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S, Wolf H, Orntoft TF. Dyrskjøt L, et al. Among authors: orntoft tf. Nat Genet. 2003 Jan;33(1):90-6. doi: 10.1038/ng1061. Epub 2002 Dec 9. Nat Genet. 2003. PMID: 12469123

8

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

Dyrskjøt L, Kruhøffer M, Thykjaer T, Marcussen N, Jensen JL, Møller K, Ørntoft TF. Dyrskjøt L, et al. Among authors: orntoft tf. Cancer Res. 2004 Jun 1;64(11):4040-8. doi: 10.1158/0008-5472.CAN-03-3620. Cancer Res. 2004. PMID: 15173019

9

A molecular signature in superficial bladder carcinoma predicts clinical outcome.

Dyrskjøt L, Zieger K, Kruhøffer M, Thykjaer T, Jensen JL, Primdahl H, Aziz N, Marcussen N, Møller K, Orntoft TF. Dyrskjøt L, et al. Among authors: orntoft tf. Clin Cancer Res. 2005 Jun 1;11(11):4029-36. doi: 10.1158/1078-0432.CCR-04-2095. Clin Cancer Res. 2005. PMID: 15930337

10

Recent developments in molecular profiling of bladder cancer.

Ørntoft TF, Zieger K, Dyrskjøt L. Ørntoft TF, et al. Curr Opin Urol. 2006 Sep;16(5):377-81. doi: 10.1097/01.mou.0000240313.16324.d3. Curr Opin Urol. 2006. PMID: 16905986 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters